| Keyword | CPC | PCC | Volume | Score | Length of keyword |
|---|---|---|---|---|---|
| cybord daratumumab myeloma | 0.28 | 0.6 | 3370 | 92 | 26 |
| cybord | 0.35 | 0.5 | 7785 | 22 | 6 |
| daratumumab | 0.08 | 0.4 | 8460 | 79 | 11 |
| myeloma | 1.62 | 0.2 | 9136 | 62 | 7 |
| Keyword | CPC | PCC | Volume | Score |
|---|---|---|---|---|
| cybord daratumumab myeloma | 0.29 | 0.7 | 596 | 49 |
| daratumumab cybord for multiple myeloma | 0.1 | 0.4 | 6763 | 100 |
| daratumumab for multiple myeloma | 1.53 | 0.3 | 21 | 3 |
| daratumumab treatment for multiple myeloma | 0.12 | 0.5 | 941 | 60 |
| dara cybord multiple myeloma | 0.95 | 0.9 | 2098 | 28 |
| daratumumab maintenance multiple myeloma | 0.94 | 0.9 | 8277 | 55 |
| daratumumab maintenance for myeloma | 1.79 | 1 | 224 | 41 |
| cybord regimen for multiple myeloma | 1.35 | 1 | 3722 | 82 |
| daratumumab multiple myeloma nice | 1.89 | 0.3 | 1353 | 86 |
| daratumumab and carfilzomib multiple myeloma | 0.44 | 0.4 | 6506 | 57 |
| daratumumab first line myeloma | 0.19 | 0.1 | 7037 | 74 |
| daratumumab dexamethasone multiple myeloma | 1.72 | 0.2 | 1363 | 54 |
| multiple myeloma daratumumab immunofixation | 0.2 | 0.2 | 4642 | 22 |
| when was daratumumab approved for myeloma | 0.5 | 0.2 | 7939 | 26 |
